Osmitrol Injection in Aviva (Mannitol Injection in Aviva Plastic Container) Drug Information: Overdosage and Contraindications

Pill Identifier Search

May 27, 2012

Osmitrol in Aviva

Glaucoma »

What is glaucoma?

Glaucoma is a disease of the major nerve of vision, called the optic nerve. The optic nerve receives light-generated nerve impulses from the retina and transmits these to the brain, where we recognize those electrical signals as vision. Glaucoma is characterized by a particular pattern of progressive damage to the optic nerve that generally begins with a subtle loss of side vision (peripheral vision). If glaucoma is not diagnosed and treated, it can progress to loss of central vision and blindness.

Glaucoma is usually, but not always, associated with elevated pressure in the eye (intraocular pressure). Generally, it is this elevated eye pressure that leads to damage of the eye (optic) nerve. In some cases, glaucoma may occur in the presence of normal eye pressure. This form of glaucoma is believed to be caused by poor regulation of blood flow to the optic nerve.

How common is glaucoma?

Worldwide, glaucoma...

Read the Glaucoma article »

« Previous
1
2
3
4
5
6
7
8
9
10
Next »

Osmitrol Injection in Aviva

Heart Disease Slideshow Pictures

Medical Illustrations of the Heart Image Collection

Take the Heart Disease Quiz!

font size

OVERDOSE

No information provided.

CONTRAINDICATIONS

Osmitrol Injection (Mannitol Injection, USP) is contraindicated in patients with:

Well established anuria due to severe renal disease, severe pulmonary congestion or frank pulmonary edema, active intracranial bleeding except during craniotomy, severe dehydration, Progressive renal damage or dysfunction after institution of mannitol therapy, including increasing oliguria and azotemia, and progressive heart failure or pulmonary congestion after institution of mannitol therapy.